Related Experiment Video
Updated: Jul 15, 2026

Mouse Genome Engineering Using Designer Nucleases
Published on: April 2, 2014
Nonlethal detection of transgene expression in the CNS of founder mice
T Wakabayashi1, A Messing, M Brenner
1National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.
Abstract:
Determining whether transgenes targeted to the central nervous system (CNS) are expressed has previously required sacrificing the animal; thus, if a line was to be maintained, it was necessary to generate offspring from the original founder mouse before assay. We describe a method for assaying for the expression of a variety of CNS-targeted transgenes that allows for the survival of the founder mice. Many CNS genes are expressed in the retina, which can be obtained from a mouse by simple survival surgery. We demonstrate that reverse transcription PCR of RNA isolated from a single eye can detect the mRNAs for glial fibrillary acidic protein (GFAP), vimentin, neurofilament light chain (NF-68) and Thy-1, all of whose promoters have been used to direct transgene expression in the CNS. We also show that this method readily detects expression of an astrocyte-specific GFAP-driven lacZ transgene and a neuron-specific L7-driven lacZ transgene.
Related Concept Videos
In-vitro Mutagenesis
Reporter Genes
Commonly used reporter...

